| pubmed-article:10695913 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C0006684 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C0205042 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C0019010 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:10695913 | lifeskim:mentions | umls-concept:C0766108 | lld:lifeskim |
| pubmed-article:10695913 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10695913 | pubmed:dateCreated | 2000-3-9 | lld:pubmed |
| pubmed-article:10695913 | pubmed:abstractText | The aim was to evaluate the use of clevidipine, a new vascular selective, ultra-short-acting calcium antagonist for blood pressure control after coronary artery bypass grafting (CABG). | lld:pubmed |
| pubmed-article:10695913 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10695913 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10695913 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10695913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10695913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10695913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10695913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10695913 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10695913 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10695913 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10695913 | pubmed:issn | 0001-5172 | lld:pubmed |
| pubmed-article:10695913 | pubmed:author | pubmed-author:NordlanderMM | lld:pubmed |
| pubmed-article:10695913 | pubmed:author | pubmed-author:RickstenS ESE | lld:pubmed |
| pubmed-article:10695913 | pubmed:author | pubmed-author:Kieler-Jensen... | lld:pubmed |
| pubmed-article:10695913 | pubmed:author | pubmed-author:Jolin-Mellgår... | lld:pubmed |
| pubmed-article:10695913 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10695913 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:10695913 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10695913 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10695913 | pubmed:pagination | 186-93 | lld:pubmed |
| pubmed-article:10695913 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:meshHeading | pubmed-meshheading:10695913... | lld:pubmed |
| pubmed-article:10695913 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10695913 | pubmed:articleTitle | Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. | lld:pubmed |
| pubmed-article:10695913 | pubmed:affiliation | Department of Anaesthesia and Intensive Care, Sahlgrenska University Hospital, Göteborg, Sweden. | lld:pubmed |
| pubmed-article:10695913 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10695913 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10695913 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10695913 | lld:pubmed |
